Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILIT follow-up 5-6 years after birch and grass treatment
NCT04296474Phase 2Completed
- Start
- May 2018
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of birch allergen extract + grass allergen extract in allergic rhinitis (AR). Started May 2018; status: completed.
02
Drugs
birch allergen extract + grass allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04296474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04296474.